Registry of Multimodality Treatment for Brain Arteriovenous Malformation in Mainland China
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chen Xiaolin, MD
Beijing Neurosurgical Institute
Principal Investigator - Li Youxiang, MD
Beijing Neurosurgical Institute
Principal Investigator - Liu Ali, MD
Beijing Neurosurgical Institute
Principal Investigator - Wang Shuo, MD
Beijing Tiantan Hospital
Study Chair - Zhao Yuanli, MD
Beijing Neurosurgical Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Capital Medical University Affiliated Beijing Tiantan Hospital
Beijing, Beijing Municipality, China
Chen Yu, MDHan Heze, MDLi Ruinan, MDLi Zhipeng, MDMeng Xiangyu, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Aug 2011
- Primary completion
- 1 Apr 2032
- Completion
- 1 Apr 2033
- Last update posted
- 23 May 2022
- Registered enrollment
- 2,000
- Registry id
- NCT04572568
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.